{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:40:27Z","timestamp":1790797227610,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T00:00:00Z","timestamp":1386720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10549-013-2799-0","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T03:45:46Z","timestamp":1386647146000},"page":"227-237","source":"Crossref","is-referenced-by-count":24,"title":["Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin"],"prefix":"10.1007","volume":"143","author":[{"given":"Dareen M.","family":"Abdelaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana V.","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,11]]},"reference":[{"issue":"2","key":"2799_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69\u201390. doi: 10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"2799_CR2","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22(14):2942\u20132953. doi: 10.1200\/jco.2004.08.181","journal-title":"J Clin Oncol"},{"issue":"6","key":"2799_CR3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/13543784.2012.679928","volume":"21","author":"M Mackiewicz-Wysocka","year":"2012","unstructured":"Mackiewicz-Wysocka M, Pankowska M, Wysocki PJ (2012) Progress in the treatment of bone metastases in cancer patients. Expert Opin Investig Drugs 21(6):785\u2013795. doi: 10.1517\/13543784.2012.679928","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"2799_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06244.x","volume":"1237","author":"R Faccio","year":"2011","unstructured":"Faccio R (2011) Immune regulation of the tumor\/bone vicious cycle. Ann N Y Acad Sci 1237(1):71\u201378. doi: 10.1111\/j.1749-6632.2011.06244.x","journal-title":"Ann N Y Acad Sci"},{"issue":"8 Suppl","key":"2799_CR5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","volume":"80","author":"GR Mundy","year":"1997","unstructured":"Mundy GR (1997) Mechanisms of bone metastasis. Cancer 80(8 Suppl):1546\u20131556. doi: 10.1002\/(SICI)1097-0142(19971015)80:8+<1546:AID-CNCR4>3.0.CO;2-I","journal-title":"Cancer"},{"issue":"20 Pt 2","key":"2799_CR6","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(20 Pt 2):6243s\u20136249s. doi: 10.1158\/1078-0432.ccr-06-0931","journal-title":"Clin Cancer Res"},{"key":"2799_CR7","doi-asserted-by":"crossref","unstructured":"Jimenez Andrade JM, Mantyh P (2010) Cancer pain: from the development of mouse models to human clinical trials. In: Kruger L, Light AR (eds) Translational pain research: from mouse to man. CRC Press, Boca Raton. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK57270\/","DOI":"10.1201\/9781439812105-c4"},{"issue":"6","key":"2799_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1634\/theoncologist.5-6-463","volume":"5","author":"RE Coleman","year":"2000","unstructured":"Coleman RE (2000) Management of bone metastases. Oncologist 5(6):463\u2013470. doi: 10.1634\/theoncologist.5-6-463","journal-title":"Oncologist"},{"issue":"1","key":"2799_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SPC.0b013e32835017e7","volume":"6","author":"AK Bhaskar","year":"2012","unstructured":"Bhaskar AK (2012) Interventional management of cancer pain. Curr Opin Support Palliat Care 6(1):1\u20139. doi: 10.1097\/SPC.0b013e32835017e7","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"2799_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2004.09.009","volume":"56","author":"BK Law","year":"2005","unstructured":"Law BK (2005) Rapamycin: an anti-cancer immunosuppressant? Crit Rev Oncol Hematol 56(1):47\u201360. doi: 10.1016\/j.critrevonc.2004.09.009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2799_CR11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","volume":"13","author":"H P\u00f3pulo","year":"2012","unstructured":"P\u00f3pulo H, Lopes JM, Soares P (2012) The mTOR signalling pathway in human cancer. Int J Mol Sci 13(2):1886\u20131918. doi: 10.3390\/ijms13021886","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2799_CR12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1369\/jhc.4A6378.2004","volume":"52","author":"Y Nakano","year":"2004","unstructured":"Nakano Y, Toyosawa S, Takano Y (2004) Eccentric localization of osteocytes expressing enzymatic activities, protein, and mRNA signals for type 5 tartrate-resistant acid phosphatase (TRAP). J Histochem Cytochem 52(11):1475\u20131482. doi: 10.1369\/jhc.4A6378.2004","journal-title":"J Histochem Cytochem"},{"issue":"19","key":"2799_CR13","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1158\/1078-0432.CCR-06-2837","volume":"13","author":"CH Lu","year":"2007","unstructured":"Lu CH, Wyszomierski SL, Tseng LM, Sun MH, Lan KH, Neal CL, Mills GB, Hortobagyi GN, Esteva FJ, Yu D (2007) Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency. Clin Cancer Res 13(19):5883\u20135888. doi: 10.1158\/1078-0432.ccr-06-2837","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2799_CR14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M, Burris HA, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN (2012) Everolimus in postmenopausal hormone-receptor\u2013positive advanced breast cancer. N Engl J Med 366(6):520\u2013529. doi: 10.1056\/NEJMoa1109653","journal-title":"N Engl J Med"},{"issue":"5","key":"2799_CR15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0168-8278(03)00428-8","volume":"39","author":"F Conti","year":"2003","unstructured":"Conti F, Morelon E, Calmus Y (2003) Immunosuppressive therapy in liver transplantation. J Hepatol 39(5):664\u2013678. doi: 10.1016\/S0168-8278(03)00428-8","journal-title":"J Hepatol"},{"issue":"2","key":"2799_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2011.09.026","volume":"314","author":"O Hussein","year":"2012","unstructured":"Hussein O, Tiedemann K, Murshed M, Komarova SV (2012) Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases. Cancer Lett 314(2):176\u2013184. doi: 10.1016\/j.canlet.2011.09.026","journal-title":"Cancer Lett"},{"issue":"11","key":"2799_CR17","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.pain.2011.07.025","volume":"152","author":"I Obara","year":"2011","unstructured":"Obara I, Tochiki KK, G\u00e9ranton SM, Carr FB, Lumb BM, Liu Q, Hunt SP (2011) Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice. Pain 152(11):2582\u20132595. doi: 10.1016\/j.pain.2011.07.025","journal-title":"Pain"},{"issue":"2","key":"2799_CR18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.mlr.0000108746.69256.45","volume":"42","author":"KP Weinfurt","year":"2004","unstructured":"Weinfurt KP, Castel LD, Li Y, Timbie JW, Glendenning GA, Schulman KA (2004) Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Med Care 42(2):164\u2013175. doi: 10.1097\/01.mlr.0000108746.69256.45","journal-title":"Med Care"},{"issue":"24","key":"2799_CR19","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","volume":"19","author":"MJ Schwei","year":"1999","unstructured":"Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, Clohisy DR, Mantyh PW (1999) Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19(24):10886\u201310897. doi: PMid:10594070","journal-title":"J Neurosci"},{"issue":"1","key":"2799_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05429.x","volume":"1198","author":"JM Jimenez-Andrade","year":"2010","unstructured":"Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW (2010) Bone cancer pain. Ann N Y Acad Sci 1198(1):173\u2013181. doi: 10.1111\/j.1749-6632.2009.05429.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2799_CR21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pain.2013.02.033","volume":"154","author":"GL Currie","year":"2013","unstructured":"Currie GL, Delaney A, Bennett MI, Dickenson AH, Egan KJ, Vesterinen HM, Sena ES, Macleod MR, Colvin LA, Fallon MT (2013) Animal models of bone cancer pain: systematic review and meta-analyses. Pain 154(6):917\u2013926. doi: 10.1016\/j.pain.2013.02.033","journal-title":"Pain"},{"issue":"S3","key":"2799_CR22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.11150","volume":"97","author":"TJ Rosol","year":"2003","unstructured":"Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH (2003) Animal models of bone metastasis. Cancer 97(S3):748\u2013757. doi: 10.1002\/cncr.11150","journal-title":"Cancer"},{"issue":"2","key":"2799_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006689719505","volume":"17","author":"M Lelekakis","year":"1999","unstructured":"Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J, Anderson RL (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17(2):163\u2013170. doi: 10.1023\/a:1006689719505","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"2799_CR24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ijc.23157","volume":"122","author":"P Zwolak","year":"2008","unstructured":"Zwolak P, Dudek AZ, Bodempudi VD, Nguyen J, Hebbel RP, Gallus NJ, Ericson ME, Goblirsch MJ, Clohisy DR (2008) Local irradiation in combination with bevacizumab enhances radiation control of bone destruction and cancer-induced pain in a model of bone metastases. Int J Cancer 122(3):681\u2013688. doi: 10.1002\/ijc.23157","journal-title":"Int J Cancer"},{"issue":"16","key":"2799_CR25","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.ejca.2008.07.011","volume":"44","author":"P Zwolak","year":"2008","unstructured":"Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Clohisy DR, Dudek AZ (2008) Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone. Eur J Cancer 44(16):2506\u20132517. doi: 10.1016\/j.ejca.2008.07.011","journal-title":"Eur J Cancer"},{"issue":"8","key":"2799_CR26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.pain.2011.03.024","volume":"152","author":"RR Hansen","year":"2011","unstructured":"Hansen RR, Nielsen CK, Nasser A, Thomsen SIM, Eghorn LF, Pham Y, Schulenburg C, Syberg S, Ding M, Stojilkovic SS, Jorgensen NR, Heegaard A-M (2011) P2X7 receptor-deficient mice are susceptible to bone cancer pain. Pain 152(8):1766\u20131776. doi: 10.1016\/j.pain.2011.03.024","journal-title":"Pain"},{"issue":"2","key":"2799_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109\u2013110. doi: 10.1016\/0304-3959(83)90201-4","journal-title":"Pain"},{"issue":"1","key":"2799_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55\u201363. doi: 10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"issue":"3","key":"2799_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0304-3959(94)90023-X","volume":"59","author":"Y Choi","year":"1994","unstructured":"Choi Y, Yoon YW, Na HS, Kim SH, Chung JM (1994) Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59(3):369\u2013376. doi: 10.1016\/0304-3959(94)90023-X","journal-title":"Pain"},{"issue":"1","key":"2799_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32(1):77\u201388. doi: 10.1016\/0304-3959(88)90026-7","journal-title":"Pain"},{"issue":"5","key":"2799_CR31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","volume":"6","author":"P Honore","year":"2000","unstructured":"Honore P, Luger NM, Sabino MAC, Schwei MJ, Rogers SD, Mach DB, O\u2019Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6(5):521\u2013528. doi: 10.1038\/74999","journal-title":"Nat Med"},{"issue":"12","key":"2799_CR32","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/jor.21474","volume":"29","author":"HA Cole","year":"2011","unstructured":"Cole HA, Ichikawa J, Colvin DC, O\u2019Rear L, Schoenecker JG (2011) Quantifying intra-osseous growth of osteosarcoma in a murine model with radiographic analysis. J Orthop Res 29(12):1957\u20131962. doi: 10.1002\/jor.21474","journal-title":"J Orthop Res"},{"issue":"1\u20133","key":"2799_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1\u20133):3\u201333. doi: 10.1016\/S0014-2999(03)01272-X","journal-title":"Eur J Pharmacol"},{"key":"2799_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","volume":"211","author":"M Barrot","year":"2012","unstructured":"Barrot M (2012) Tests and models of nociception and pain in rodents. Neuroscience 211:39\u201350. doi: 10.1016\/j.neuroscience.2011.12.041","journal-title":"Neuroscience"},{"issue":"4","key":"2799_CR35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpain.2011.12.006","volume":"13","author":"MH Shih","year":"2012","unstructured":"Shih MH, Kao SC, Wang W, Yaster M, Tao YX (2012) Spinal cord NMDA receptor-mediated activation of mammalian target of rapamycin is required for the development and maintenance of bone cancer-induced pain hypersensitivities in rats. J Pain 13(4):338\u2013349. doi: 10.1016\/j.jpain.2011.12.006","journal-title":"J Pain"},{"issue":"1","key":"2799_CR36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00000542-200501000-00022","volume":"102","author":"T Donovan-Rodriguez","year":"2005","unstructured":"Donovan-Rodriguez T, Dickenson AH, Urch CE (2005) Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology 102(1):132\u2013140. doi: 10.1097\/00000542-200501000-00022","journal-title":"Anesthesiology"},{"issue":"1","key":"2799_CR37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bone.2010.07.009","volume":"48","author":"T Yoneda","year":"2011","unstructured":"Yoneda T, Hata K, Nakanishi M, Nagae M, Nagayama T, Wakabayashi H, Nishisho T, Sakurai T, Hiraga T (2011) Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone 48(1):100\u2013105. doi: 10.1016\/j.bone.2010.07.009","journal-title":"Bone"},{"issue":"5","key":"2799_CR38","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1179\/joc.2005.17.5.555","volume":"17","author":"F Fulfaro","year":"2005","unstructured":"Fulfaro F, Leto G, Badalamenti G, Arcara C, Cicero G, Valerio MR, Di Fede G, Russo A, Vitale A, Rini GB, Casuccio A, Intrivici C, Gebbia N (2005) The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers. J Chemother 17(5):555\u2013559. doi: PMid:16323446","journal-title":"J Chemother"},{"issue":"3","key":"2799_CR39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ars.2011.4408","volume":"18","author":"S Basu","year":"2013","unstructured":"Basu S, Nachat-Kappes R, Caldefie-Chezet F, Vasson MP (2013) Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations. Antioxid Redox Signal 18(3):323\u2013360. doi: 10.1089\/ars.2011.4408","journal-title":"Antioxid Redox Signal"},{"issue":"20 Pt 2","key":"2799_CR40","doi-asserted-by":"crossref","first-page":"6231s","DOI":"10.1158\/1078-0432.CCR-06-0682","volume":"12","author":"MJ Goblirsch","year":"2006","unstructured":"Goblirsch MJ, Zwolak PP, Clohisy DR (2006) Biology of bone cancer pain. Clin Cancer Res 12(20 Pt 2):6231s\u20136235s. doi: 10.1158\/1078-0432.ccr-06-0682","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2799_CR41","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1200\/JCO.2012.45.5766","volume":"31","author":"GD Demetri","year":"2013","unstructured":"Demetri GD, Chawla SP, Ray-Coquard I, Le Cesne A, Staddon AP, Milhem MM, Penel N, Riedel RF, Bui-Nguyen B, Cranmer LD, Reichardt P, Bompas E, Alcindor T, Rushing D, Song Y, Lee RM, Ebbinghaus S, Eid JE, Loewy JW, Haluska FG, Dodion PF, Blay JY (2013) Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy. J Clin Oncol 31(19):2485\u20132492. doi: 10.1200\/jco.2012.45.5766","journal-title":"J Clin Oncol"},{"issue":"1","key":"2799_CR42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000348584","volume":"59","author":"SN Waqar","year":"2013","unstructured":"Waqar SN, Gopalan PK, Williams K, Devarakonda S, Govindan R (2013) A phase I trial of sunitinib and rapamycin in patients with advanced non-small cell lung cancer. Chemotherapy 59(1):8\u201313. doi: 10.1159\/000348584","journal-title":"Chemotherapy"},{"issue":"1","key":"2799_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-013-2528-8","volume":"139","author":"CX Ma","year":"2013","unstructured":"Ma CX, Suman VJ, Goetz M, Haluska P, Moynihan T, Nanda R, Olopade O, Pluard T, Guo Z, Chen HX, Erlichman C, Ellis MJ, Fleming GF (2013) A phase I trial of the IGF-1R antibody cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat 139(1):145\u2013153. doi: 10.1007\/s10549-013-2528-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2799_CR44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-03-0043","volume":"10","author":"WC Noh","year":"2004","unstructured":"Noh WC, Mondesire WH, Peng J, Jian W, Zhang H, Dong J, Mills GB, Hung MC, Meric-Bernstam F (2004) Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res 10(3):1013\u20131023. doi: 10.1158\/1078-0432.CCR-03-0043","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2799_CR45","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1158\/1078-0432.CCR-06-1331","volume":"12","author":"LK Francis","year":"2006","unstructured":"Francis LK, Alsayed Y, Leleu X, Jia X, Singha UK, Anderson J, Timm M, Ngo H, Lu G, Huston A, Ehrlich LA, Dimmock E, Lentzsch S, Hideshima T, Roodman GD, Anderson KC, Ghobrial IM (2006) Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma. Clin Cancer Res 12(22):6826\u20136835. doi: 10.1158\/1078-0432.ccr-06-1331","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2799_CR46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.27789","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer R, Salvagni S, Oliveira CT, Qian Y, Jiang Q, Dansey R, Braun A, Chung K (2013) Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119(4):832\u2013838. doi: 10.1002\/cncr.27789","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2799-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2799-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2799-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T18:44:42Z","timestamp":1564944282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2799-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,11]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2799"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2799-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,11]]}}}